Allergan Aesthetics (AbbVie) CoolSculpting Elite

Cryolipolysis · Cryolipolysis

CurrentBe the first to review

What it's actually cleared for: Cold-assisted lipolysis of abdomen, flanks, thighs, bra/back fat, banana roll, upper arms (BMI <=30) and submental area

Last verified: August 6, 2026 · How we verify

New: $150k–$250k with dual applicators|Used: $60k–$120k (legacy units $15k–$45k)market estimate, no email required

Save device

Bottom line

(Existing profile covers economics.) Buy the brand and the walk-in demand, not the margins — and model your cycle-card exposure honestly before signing.

Overview

Bottom line: buy the brand and the walk-in demand, not the margins. Model your cycle-card exposure honestly before signing and negotiate cycle bundles hard. If your market does not already know CoolSculpting by name, Emsculpt NEO or truSculpt iD money works harder. Alternatives: Emsculpt NEO, truSculpt iD, Cooltech Define (no US brand power, no cycle tax), EON. Prices are indicative 2026 US market ranges.

How it works

The science

Cryolipolysis: controlled cooling (around -11C at the cup) crystallizes lipids in fat cells, triggering apoptosis while sparing skin, nerves, and muscle, with dead adipocytes cleared over 1-3 months. Elite's dual applicators treat two areas simultaneously with redesigned C-shaped cups claiming better tissue contact and ~18% more cooling coverage than Legacy. ~20-25% fat-layer reduction per cycle in treated areas is the standard published expectation. Rare but real risk: paradoxical adipose hyperplasia (PAH) — treated fat grows instead of shrinking — which gained mainstream attention after high-profile cases; incidence estimates vary widely (roughly 1 in 2,000-4,000 cycles in published series). Every consult should disclose it.

Patented tech

Cryolipolysis itself originated from Harvard/Mass General research (Zeltiq's founding IP); Elite's C-shaped dual applicators and cup geometry are the current patent layer.

Origin

Zeltiq heritage manufacturing in Pleasanton, California under Allergan/AbbVie — verify current site.

FDA & regulatory status

Cleared via 510(k)

What it's actually cleared for:

Cold-assisted lipolysis of abdomen, flanks, thighs, bra/back fat, banana roll, upper arms (BMI <=30) and submental area

510(k) numbers

K212707; K233732

Clearance notes

K212707 / K233732 lineage — cold-assisted lipolysis of the abdomen, flanks, thighs, bra/back fat, banana roll and upper arms (BMI ≤30) and submental area (BMI ≤46.2).

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Treatment economics

Consumers pay $600–$1,500 per cycle and typical plans run 4–8 cycles ($2,000–$4,500). But every cycle sends ~$330 back to Allergan — consumables were ~45–49% of Zeltiq revenue before the acquisition and cycle-card prices have roughly tripled since the late 2010s. A busy practice can owe Allergan $400k+/year. The brand still prints demand, but per-treatment margins are the thinnest of any major body device.

What practices charge

(Existing profile.) $600-1,500 per cycle, plans 4-8 cycles, $2,000-4,500 typical total.

Consumables & recurring cost

(Existing profile.) ~$330 per cycle card to Allergan plus gel/liner kits — consumables were ~45-49% of Zeltiq revenue pre-acquisition.

Consumables (summary)

~$330 per cycle card paid to Allergan plus gel/liner kit. Service negotiated; assume five figures annually.

Ideal for

Best-fit practice

Practices in markets where "CoolSculpting" is the search term — the brand still prints demand. Best inside the Allergan/Alle ecosystem cross-selling tox and filler patients. Patients: BMI <=30 (submental <=46.2), pinchable discrete fat pockets, needle- and surgery-averse.

Compliance

Medical director & delegation

Class II prescription device; medical director oversight with delegation to trained staff in most states — verify locally.

Contraindications & screening

Cryoglobulinemia, cold agglutinin disease, paroxysmal cold hemoglobinuria (absolute — cold-triggered blood disorders), pregnancy, hernias in the treatment area, impaired sensation; PAH risk disclosure belongs in every consent.

Ownership

Warranty & service

Negotiated with Allergan; assume five figures annually class-typical; cycle-card bundle negotiations matter more than the service line.

Resale & used market

Elite used at ~$60k-120k, Legacy far cheaper ($15k-45k); liquidity good but every buyer inherits the cycle-card economics, which caps what the hardware alone is worth.

Chains using this device

  • Ideal Image

    Aesthetic chain · ~157 US locations · Chain treatment menu

    High
  • bodenvy

    Body contouring franchise · ~10 US locations · Company claims #1 US provider

    High
  • SKINNEY Medspa

    Medspa · 4 US locations · Treatment menu

    Medium
  • Red Mountain Weight Loss

    Weight loss & aesthetics · 9 US locations · Service pages

    Medium
  • LaserAway

    Aesthetic dermatology chain · ~200 US locations · Chain treatment menu

    High
  • Schweiger Dermatology Group

    Dermatology group · ~120 offices US locations · Practice service pages

    Medium
  • SkinSpirit

    Medspa · 60 US locations · Chain treatment menu

    Medium
  • OrangeTwist

    Medspa franchise · ~10 US locations · Chain treatment menu

    Medium

Owner reviews

Write a review

No approved reviews yet. Be the first owner to publish one.

Alternatives

Classys Clatuu Alpha

Cryolipolysis

Cocoon Medical (Sinclair) Cooltech

Cryolipolysis

Cocoon Medical (Sinclair) Cooltech Define

Cryolipolysis · $60k–$100k

Allergan Aesthetics (AbbVie) CoolSculpting (Legacy/Gen 1-2)

Cryolipolysis · $100k–$150k

History

Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.

  1. August 1, 2026

    Record created

    Added to The Aesthetic Index — August 2026

    Source: The Aesthetic Index editorial

Get the full State of Aesthetic Devices 2026 report

The first independent census of the US aesthetic device market — free.

Get the report